AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies

ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.

These disclosures were last reviewed on the 13-05-2024.

AIM Securities Information

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it's “principal” place of business is in the United Kingdom.

UK City Code on Takeovers and Mergers:-  Valirx is subject to the UK City Code on Takeovers and Mergers.

The Total Number of AIM Securities in issue with nominal value of 0.1p is 132,348,673

The information below was last updated on 21 June 2024.

The percentage of AIM Securities not in public hands is approximately 23%.

Our Significant Shareholder(s)

Shareholder(s) with more than 3%

ShareholdersNumber of SharesPercentage of Total
Mr Adam Hargreaves7,749,1635.89%
Sanderson Capital Partners Ltd5,000,0003.78%
Monecor (London) Ltd4,466,9693.37%

The Directors’ holding

ShareholdersNumber of SharesPercentage of Total
Directors (combined)1,845,7041.40%
Gerry Desler195,3340.15%
Suzanne Dilly483,3340.37%
Martin Lampshire294,0000.22%
Adrian de Courcey871,0360.65%
Martin GouldstoneNoneNone



Corporate Brokers

Shard Capital Partners LLP, 
70 Mark Lane,
EC3R 7NQ. 
Tel: +44 (0) 203 791 7000


Nominated Adviser

Cairn Financial Advisers LLP,
80 Cheapside,
Tel: +44 (0) 207 213 0880


Neville Registrars Limited
Neville House,
Steelpark Road,
B62 8HD
Tel: +44 (0) 121585 1131


DACBeachcroft LLP,
25 Walbrook,
Tel: +44 (0) 207 242 1011


Adler Shine LLP,
Aston House,
Cornwall Avenue,
N3 1LF
Tel: +44 (0) 208 371 3000


The Co-operative Bank,
PO Box 250,
Delph House,
United Kingdom

Corporate Governance

The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.

The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.

These arrangements are also disclosed in our Annual Report and Accounts.

These disclosures were last reviewed on the 21-06-2024.